Innovative mRNA vaccine against NSCLC

Designing a platform of targeted polymeric nanoparticles
for efficient personalized therapy.

Innovative mRNA vaccine against NSCLC

Designing a platform of targeted polymeric nanoparticles
for efficient personalized therapy.

Registration for the TumorOUT Workshop 2026 is now officially open! 🧬✨

We are excited to welcome researchers, clinicians, industry professionals, 
and students to Barcelona for two days of discussions on nanomedicine, RNA therapeutics,
targeted drug delivery, and personalized cancer therapy.

📅 15–16 June 2026
📍 IQS Barcelona – Universitat Ramon Llull, Barcelona
💻 Hybrid event (attendance in possible fully online or fully in person)
✅ In-person registration is now available
🌐 Online attendance registration will open soon
🎟️ In-person participation fee: 50€

The workshop will feature:
• Scientific sessions from the TumorOUT consortium
• Invited academic and industry speakers
• Translational and industry-focused discussions
• Networking opportunities with international partners and biotech stakeholders

About the project

We aim to design a personalized enhanced and combined nano-immunotherapeutic approach to treat lung cancer patients, based on the use of proprietary polymeric nanoparticles encapsulating nucleic acids as active principles.

These nucleic acids will:

a) act as antigens to immunize patients against tumor antigens and achieve the self-killing of tumor cells (mRNA cancer vaccination); and

b) immunomodulate the TME by silencing key immunosuppressor genes (targeted therapy).

0
participating
countries
0
collaborating
research institutes
+0
researchers
involved
0/50
gender
balance
0M
granted

Partner
members

The project is carried out with partners from different fields, building a multidisciplinary and transversal consortium. Learn more about the members and their research profiles.

Contact

If you have questions about the project or need further information, you can leave your personal information so we can contact you.

TumorOUT Workshop

IQS x NanoTherapies Labs are organizing a 2-day workshop dedicated to TumorOUT, a European collaborative project focused on next-generation nano-immunotherapy for non-small cell lung cancer (NSCLC). The event will take place on the 15th and 16th of June in IQS in Barcelona. The event is hybrid and attendees can participate fully online or in person (50EUR fee for in person participation).